Vera Therapeutics VERA Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$299.62M-96.9% | -$152.15M-58.5% | -$95.99M-7.8% | -$89.06M-173% | ||
| $468K+346% | $105K+400% | $21K+102% | -$846K-581% | ||
| $37.93M+82.3% | $20.8M+81.0% | $11.49M+29.3% | $8.89M+195% | ||
| -$241.1M-79.0% | -$134.68M-46.1% | -$92.18M-36.4% | -$67.6M-185% | ||
| $630K-35.2% | $972K+1,443% | $63K+1.6% | $62K— | ||
| $194.29M+142% | -$463.35M— | —— | —— | ||
| —— | $13K— | —— | —— | ||
| $308.9M-49.1% | $606.67M+354% | $133.54M+31.0% | $101.93M+89.2% | ||
| $262.08M+458% | $46.97M+2,335% | $1.93M— | —— | ||
| -$241.73M-78.2% | -$135.65M-47.1% | -$92.24M-36.3% | -$67.66M-185% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Vera Therapeutics generate?
- Vera Therapeutics (VERA) generated -$293.2M in operating cash flow over the trailing twelve months.
- What is Vera Therapeutics's free cash flow?
- After $466.0K of capital expenditures, Vera Therapeutics's free cash flow was -$293.7M over the trailing twelve months, down 87.8% year over year.
- Where does Vera Therapeutics's cash flow data come from?
- Every line is extracted from Vera Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.